Status:
UNKNOWN
Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study
Lead Sponsor:
Karolinska Institutet
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
In this study we cross-reference several nationwide high-quality Swedish registers in order to study risk factors for severe Covid-19 outcomes.
Detailed Description
In this nationwide, case-control study we cross-reference several detailed, high-quality Swedish registers in order to study risk factors associated with severe Covid-19 as well as different disease o...
Eligibility Criteria
Inclusion
- Cases: Admitted to intensive care unit in Sweden and registered admission in the Swedish intensive care register (SIR) with a main diagnosis of Covid-19 confirmed by laboratory testing (ICD10: U07.1). (cases)
- Control subjects matched for age, gender,residency: For each case 10 controls matched for age, gender and district of residence will be identified by Statistics Sweden (SCB) in the Swedish population register (RTB).
- Control subjects matched for age and gender: For each case 5 controls matched for age and gender will be identified by by Statistics Sweden (SCB) in the Swedish population register (RTB).
Exclusion
- No valid Swedish personal identity number (PIN)
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
22784 Patients enrolled
Trial Details
Trial ID
NCT04426084
Start Date
March 1 2020
End Date
December 31 2023
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Södersjukhuset
Stockholm, Sweden, 11883